David A. Siegel Treace Medical Concepts, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 73,100 shares of TMCI stock, worth $577,490. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,100
Previous 30,600
138.89%
Holding current value
$577,490
Previous $399,000
21.8%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TMCI
# of Institutions
127Shares Held
39.3MCall Options Held
272KPut Options Held
261K-
Armistice Capital, LLC New York, NY5.36MShares$42.3 Million0.46% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$32.1 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.68MShares$29.1 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.62MShares$28.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.83MShares$22.4 Million0.0% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $438M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...